Investing Profile

Nina Kjellson

VCInvestor
General Partner at Canaan Partners
canaan.com/team/nina-kjellsonMenlo Park, California
Photo of Nina Kjellson, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Canaan Partners General Partner
$250K - $20.0M
$10.0M
37
$800M
CompanyStageDateRound SizeTotal Raised
Actio Biosciences
Series BJun 2025$66M
Series ASep 2023$55M
$120M
Co-investors: Jason Fuller (Deerfield Management)
Rondo Therapeutics
Series AMar 2022$67M
$67M
Tyra Biosciences
Series BMar 2021$110M
Series AJan 2020$50M
$160M
Co-investors: Jake Simson (RA Capital)
Vineti
Series COct 2020$33M
Series CFeb 2020$35M
Series BApr 2018$34M
$100M
Co-investors: Marc Benioff
Trishula Therapeutics
Series UnknownAug 2020
Intrepida Bio
Series AOct 2019$10M
$10M
Dauntless Pharmaceuticals
Series AFeb 2017$25M
$25M
Welltok
Series EOct 2016$34M
Series DJan 2015$37M
Series CFeb 2014$22M
Series BApr 2013$19M
$190M
Co-investors: Mohamad Makhzoumi (New Enterprise Associates (NEA)), Kevin Spain (Emergence Capital), Blake Wu (New Enterprise Associates (NEA)), Sharon Stevenson (Okapi Venture Capital), Bruce Hallett (Miramar Ventures)